Clinical outcomes and severity of laboratory-confirmed RSV compared with influenza, parainfluenza and human metapneumovirus in Australian children attending secondary care. [PDF]
Sarna M+6 more
europepmc +1 more source
Novel insights into the host cell glycan binding profile of human metapneumovirus. [PDF]
Van Den Bergh A+4 more
europepmc +1 more source
Human metapneumovirus infection is associated with a substantial morbidity and mortality burden in adult inpatients. [PDF]
Philippot Q+37 more
europepmc +1 more source
Efficacious human metapneumovirus vaccine based on AI-guided engineering of a closed prefusion trimer. [PDF]
Bakkers MJG+15 more
europepmc +1 more source
A Case Report of Sepsis-Induced Dilated Cardiomyopathy Secondary to Human Metapneumovirus Infection. [PDF]
Ingram T, Evbuomwan MO, Jyothidasan A.
europepmc +1 more source
COVID-19 pandemic-altered epidemiology of respiratory syncytial virus and human metapneumovirus infections in young children. [PDF]
Nagasawa M+7 more
europepmc +1 more source
Author Correction: Mucosal bivalent live attenuated vaccine protects against human metapneumovirus and respiratory syncytial virus in mice. [PDF]
Ogonczyk-Makowska D+19 more
europepmc +1 more source
Changes in the epidemiological patterns of respiratory syncytial virus and human metapneumovirus infection among pediatric patients and their correlation with severe cases: a long-term retrospective study. [PDF]
Kuang L+7 more
europepmc +1 more source
Interleukin-1β promotes human metapneumovirus replication via activating the cGAS-STING pathway. [PDF]
Wu G+5 more
europepmc +1 more source